BridgeBio Oncology Therapeutics Inc BBOT Q1 2026 Earnings NarrowerThanExpected Loss Fails to Stem Stock Slide NTRS Q1 2026 Earnings EPS Surges 143 Above Estimates Amid Solid Operating Performance XOM Q1 2026 Earnings Solid EPS Beat of 143 Despite Flat Revenue Environment TME Q1 2026 Earnings EPS Beats Estimates Amid Undisclosed Revenue Figures EL Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Rally AMBR Q4 2025 Earnings EPS Misses Estimates by Narrow Margin Shares Decline